Inventor · disambiguated record
Susanne Hipp
Also filed as: HIPP SUSANNE
10 granted patents·4 pending applications·207 citations·filing 2012–2025
90Inventor score
Top patents by PatentIndex Score
14 records- 0198US9340621B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2012·Granted May 17, 2016·91 cites·15 claims
- 0297US9150664B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2012·Granted Oct 6, 2015·64 cites·15 claims
- 0394US9598500B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2012·Granted Mar 21, 2017·22 cites·15 claims
- 0493US11332541B2Multi-specific binding proteins for cancer treatmentBOEHRINGER INGELHEIM INT·Filed 2019·Granted May 17, 2022·8 cites·17 claims
- 0592US12173083B2Multi-specific binding proteins for cancer treatmentBOEHRINGER INGELHEIM INT·Filed 2022·Granted Dec 24, 2024·2 cites·18 claims
- 0692US10766969B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2012·Granted Sep 8, 2020·8 cites·29 claims
- 0790US12281176B2Binding molecules for BCMA and CD3AMGEN INC·Filed 2021·Granted Apr 22, 2025·1 cites·7 claims
- 0890US10752694B2Binding molecules for BCMA and CD3AMGEN RES MUNICH GMBH·Filed 2014·Granted Aug 25, 2020·11 cites·15 claims
- 0981US2022251243A1Binding molecules for bcma and cd3AMGEN INC·Filed 2022·Application pending·0 cites
- 1078US2025346684A1Binding molecules for bcma and cd3AMGEN INC·Filed 2025·Application pending·0 cites
- 1176US12281175B2Binding molecules for BCMA and CD3AMGEN INC·Filed 2020·Granted Apr 22, 2025·0 cites·16 claims
- 1271US2023340130A1Multi-specific binding proteins for cancer treatmentBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1364US2024383981A1Uses of t cell engaging proteins in the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1460US11732045B2Multi-specific binding proteins for cancer treatmentBOEHRINGER INGELHEIM INT·Filed 2020·Granted Aug 22, 2023·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Susanne Hipp files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →